| 1 | [SID56320729] | Active | EC50 | 0.096 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity [AID1902, Type: confirmatory] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | EC50 | 0.096 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Inhibitors of Streptokinase Promotor Activity | | AID | 1902 | | BioAssay type | confirmatory | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 2 | [SID56320729] | Active | EC50 | 0.098 | Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus [AID1915, Type: confirmatory] | |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | EC50 | 0.098 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Response HTS to Identify Compounds Cytotoxic to Streptococcus | | AID | 1915 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 3 | [SID56320729] | Active | EC50 | 0.099 | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus [AID1900, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | EC50 | 0.099 [uM] | | BioAssay | Luminescence Microorganism-Based Dose Confirmation HTS to Identify Compounds Cytotoxic to SK(-)GAS Group A Streptococcus | | AID | 1900 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID56320728] | Active | AC50 | 1.168 | High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_Dose_CherryPick_Activity_Set2 [AID504941, Type: confirmatory] | TatABCE protein translocation system subunit [Escherichia coli str. K-12 substr. MG1655] [gi:90111653] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | AC50 | 1.168 [uM] | | BioAssay | High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_Dose_CherryPick_Activity_Set2 | | AID | 504941 | | BioAssay type | confirmatory | | Target | TatABCE protein translocation system subunit [Escherichia coli str. K-12 substr. MG1655] [gi:90111653] | | PubMed | | | Data Table |  |
|
| 5 | [SID56320728] | Active | Potency | 2.0787 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation [AID504834, Type: confirmatory] | |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | Potency | 2.0787 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation | | AID | 504834 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 6 | [SID56320729] | Active | IC50 | 5.95 | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media [AID449762, Type: confirmatory] | |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | IC50 | 5.95 [uM] | | BioAssay | High Throughput Screening Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in 7H9 Media | | AID | 449762 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 7 | [SID56320728] | Active | Potency | 7.3753 | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation [AID504832, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | Potency | 7.3753 [uM] | | BioAssay | Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation | | AID | 504832 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID56320728] | Active | Potency | 8.1995 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | Potency | 8.1995 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 9 | [SID56320729] | Active | IC50 | 9.73 | A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of Glycerol [AID449764, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | IC50 | 9.73 [uM] | | BioAssay | A High Throughput Confirmatory Assay used to Identify Novel Compounds that Inhibit Mycobacterium Tuberculosis in the absence of Glycerol | | AID | 449764 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID56320728] | Active | Potency | 10 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 11 | [SID56320728] | Active | Potency | 10 | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a [AID504332, Type: confirmatory] | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a | | AID | 504332 | | BioAssay type | confirmatory | | Target | euchromatic histone-lysine N-methyltransferase 2 [Homo sapiens] [gi:168985070] | | PubMed | | | Data Table |  |
|
| 12 | [SID56320728] | Active | Potency | 15.8489 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 13 | [SID56320728] | Active | Potency | 15.8489 | qHTS Assay for the Inhibitors of L3MBTL1 [AID485360, Type: confirmatory] | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | Potency | 15.8489 [uM] | | BioAssay | qHTS Assay for the Inhibitors of L3MBTL1 | | AID | 485360 | | BioAssay type | confirmatory | | Target | lethal(3)malignant brain tumor-like protein 1 isoform I [Homo sapiens] [gi:117938328] | | PubMed | | | Data Table |  |
|
| 14 | [SID56320728] | Active | Potency | 18.3564 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | Potency | 18.3564 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID56320728] | Active | AC50 | 19.873 | Bacterial Growth Inhibition Counterscreen using BacTiter-Glo Measured in Microorganism System Using Plate Reader - 2093-02_Inhibitor_Dose_CherryPick_Activity [AID504843, Type: confirmatory] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | AC50 | 19.873 [uM] | | BioAssay | Bacterial Growth Inhibition Counterscreen using BacTiter-Glo Measured in Microorganism System Using Plate Reader - 2093-02_Inhibitor_Dose_CherryPick_Activity | | AID | 504843 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID56320728] | Active | Potency | 25.1189 | qHTS Assay for Inhibitors of BAZ2B [AID504333, Type: confirmatory] | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | Potency | 25.1189 [uM] | | BioAssay | qHTS Assay for Inhibitors of BAZ2B | | AID | 504333 | | BioAssay type | confirmatory | | Target | bromodomain adjacent to zinc finger domain 2B [Homo sapiens] [gi:6683500] | | PubMed | | | Data Table |  |
|
| 17 | [SID56320729] | Active | CC50 | 40 | A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Mycobacterium Tuberculosis [AID435019, Type: confirmatory] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | CC50 | 40 [uM] | | BioAssay | A Cell Based Secondary Assay To Explore Cytotoxicity of Compounds that Inhibit Mycobacterium Tuberculosis | | AID | 435019 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID56320728] | Active | Potency | 79.4328 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 19 | [SID56320728] | Active | Potency | 79.4328 | qHTS for Inhibitors of Polymerase Kappa [AID588579, Type: confirmatory] | DNA polymerase kappa [Homo sapiens] [gi:7705344] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | Potency | 79.4328 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Kappa | | AID | 588579 | | BioAssay type | confirmatory | | Target | DNA polymerase kappa [Homo sapiens] [gi:7705344] | | PubMed | | | Data Table |  |
|
| 20 | [SID56320729] | Active | | | Counterscreen for inhibitors of RecBCD: Absorbance-based cell-based high throughput assay to identify inhibitors of bacterial viability [AID651983, Type: screening] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of RecBCD: Absorbance-based cell-based high throughput assay to identify inhibitors of bacterial viability | | AID | 651983 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID56320728] | Active | | | uHTS identification of SUMO1-mediated protein-protein interactions [AID602429, Type: screening] | SUMO-1 [Homo sapiens] [gi:1762973] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | BioAssay | uHTS identification of SUMO1-mediated protein-protein interactions | | AID | 602429 | | BioAssay type | screening | | Target | SUMO-1 [Homo sapiens] [gi:1762973] | | PubMed | | | Data Table |  |
|
| 22 | [SID56320729] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 23 | [SID56320729] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) [AID463082, Type: screening] | PLA2G7 gene product [Homo sapiens] [gi:270133071] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of the plasma platelet activating factor acetylhydrolase (pPAFAH) | | AID | 463082 | | BioAssay type | screening | | Target | PLA2G7 gene product [Homo sapiens] [gi:270133071] | | PubMed | | | Data Table |  |
|
| 24 | [SID56320728] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3) [AID492972, Type: screening] | platelet-activating factor acetylhydrolase IB subunit gamma [Homo sapiens] [gi:225543099] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of human platelet-activating factor acetylhydrolase 1B, catalytic subunit 3 (PAFAH1B3) | | AID | 492972 | | BioAssay type | screening | | Target | platelet-activating factor acetylhydrolase IB subunit gamma [Homo sapiens] [gi:225543099] | | PubMed | | | Data Table |  |
|
| 25 | [SID56320729] | Active | | | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe [AID651800, Type: screening] | TCRAV4S1 [Homo sapiens] [gi:2358024] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Fluorescence-based biochemical primary high throughput assay to identify inhibitors of T-cell receptor (TCR)-CD3 interaction using a TAMRA-labeled TCR probe | | AID | 651800 | | BioAssay type | screening | | Target | TCRAV4S1 [Homo sapiens] [gi:2358024] | | PubMed | | | Data Table |  |
|
| 26 | [SID56320728] | Active | | | High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity [AID488895, Type: screening] | TatABCE protein translocation system subunit [Escherichia coli str. K-12 substr. MG1655] [gi:90111653] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | BioAssay | High Throughput Screen for Tat Transport Inhibitors Measured in Microorganism System Using Plate Reader - 2093-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 488895 | | BioAssay type | screening | | Target | TatABCE protein translocation system subunit [Escherichia coli str. K-12 substr. MG1655] [gi:90111653] | | PubMed | | | Data Table |  |
|
| 27 | [SID56320729] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 28 | [SID56320729] | Active | | | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). [AID1974, Type: screening] | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Fluorescence polarization-based counterscreen for RBBP9 inhibitors: primary biochemical high throughput screening assay to identify inhibitors of the oxidoreductase glutathione S-transferase omega 1(GSTO1). | | AID | 1974 | | BioAssay type | screening | | Target | glutathione S-transferase omega-1 isoform 1 [Homo sapiens] [gi:4758484] | | PubMed | | | Data Table |  |
|
| 29 | [SID56320729] | Active | | | Absorbance-based bacterial cell-based high throughput confirmation assay to identify inhibitors of RecBCD [AID651982, Type: screening] | exonuclease V (RecBCD complex), alpha chain [Escherichia coli str. K-12 substr. MG1655] [gi:16130723] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Absorbance-based bacterial cell-based high throughput confirmation assay to identify inhibitors of RecBCD | | AID | 651982 | | BioAssay type | screening | | Target | exonuclease V (RecBCD complex), alpha chain [Escherichia coli str. K-12 substr. MG1655] [gi:16130723] | | PubMed | | | Data Table |  |
|
| 30 | [SID56320729] | Active | | | Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage) [AID651602, Type: screening] | exonuclease V (RecBCD complex), alpha chain [Escherichia coli str. K-12 substr. MG1655] [gi:16130723] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of RecBCD (with phage) | | AID | 651602 | | BioAssay type | screening | | Target | exonuclease V (RecBCD complex), alpha chain [Escherichia coli str. K-12 substr. MG1655] [gi:16130723] | | PubMed | | | Data Table |  |
|
| 31 | [SID56320729] | Active | | | Counterscreen for AddAB inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of RecBCD [AID488955, Type: screening] | exonuclease V (RecBCD complex), alpha chain [Escherichia coli str. K-12 substr. MG1655] [gi:16130723] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Counterscreen for AddAB inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of RecBCD | | AID | 488955 | | BioAssay type | screening | | Target | exonuclease V (RecBCD complex), alpha chain [Escherichia coli str. K-12 substr. MG1655] [gi:16130723] | | PubMed | | | Data Table |  |
|
| 32 | [SID56320729] | Active | | | Absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of AddAB recombination protein complex [AID488942, Type: screening] | hypothetical protein HP1089 [Helicobacter pylori 26695] [gi:15645703] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of AddAB recombination protein complex | | AID | 488942 | | BioAssay type | screening | | Target | hypothetical protein HP1089 [Helicobacter pylori 26695] [gi:15645703] | | PubMed | | | Data Table |  |
|
| 33 | [SID56320729] | Active | | | Counterscreen for RECBCD inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of AddAB recombination protein complex [AID651984, Type: screening] | hypothetical protein HP1089 [Helicobacter pylori 26695] [gi:15645703] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Counterscreen for RECBCD inhibitors: absorbance-based high throughput cell-based assay to identify inhibitors of AddAB recombination protein complex | | AID | 651984 | | BioAssay type | screening | | Target | hypothetical protein HP1089 [Helicobacter pylori 26695] [gi:15645703] | | PubMed | | | Data Table |  |
|
| 34 | [SID56320729] | Active | | | Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex [AID435030, Type: screening] | hypothetical protein HP1089 [Helicobacter pylori 26695] [gi:15645703] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Absorbance-based primary bacterial cell-based high throughput screening assay to identify inhibitors of AddAB recombination protein complex | | AID | 435030 | | BioAssay type | screening | | Target | hypothetical protein HP1089 [Helicobacter pylori 26695] [gi:15645703] | | PubMed | | | Data Table |  |
|
| 35 | [SID56320729] | Active | | | MLPCN Streptokinase Expression Inhibition [AID1662, Type: screening] | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | MLPCN Streptokinase Expression Inhibition | | AID | 1662 | | BioAssay type | screening | | Target | streptokinase A precursor [Streptococcus pyogenes M1 GAS] [gi:15675770] | | PubMed | | | Data Table |  |
|
| 36 | [SID56320729] | Active | | | Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability [AID449728, Type: screening] | |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of AddAB: absorbance-based bacterial cell-based high throughput screening assay to identify inhibitors of bacterial viability | | AID | 449728 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 37 | [SID56320729] | Active | | | Counterscreen for AddAB inhibitors: absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of bacterial viability [AID488956, Type: screening] | |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Counterscreen for AddAB inhibitors: absorbance-based bacterial cell-based high throughput confirmation assay for inhibitors of bacterial viability | | AID | 488956 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 38 | [SID56320728] | Active | | | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter [AID540364, Type: screening] | |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify activators of the GAA850 frataxin (FXN) promoter | | AID | 540364 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 39 | [SID56320729] | Active | | | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 [AID652115, Type: screening] | |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | MLPCN SirT-5 Measured in Biochemical System Using Imaging - 7044-01_Inhibitor_SinglePoint_HTS_Activity_Set5 | | AID | 652115 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 40 | [SID56320728] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 41 | [SID56320728] | Active | | | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay [AID588458, Type: screening] | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Active | | BioAssay | uHTS identification of DNMT1 inhibitors in a Fluorescent Molecular Beacon assay | | AID | 588458 | | BioAssay type | screening | | Target | DNA (cytosine-5)-methyltransferase 1 isoform b [Homo sapiens] [gi:4503351] | | PubMed | | | Data Table |  |
|
| 42 | [SID56320729] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 43 | [SID56320729] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 44 | [SID56320729] | Active | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Active | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 45 | [SID56320728] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 46 | [SID56320728] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 47 | [SID56320728] | Inactive | | | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) [AID602281, Type: screening] | ABHD5 gene product [Homo sapiens] [gi:31542303] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Inactive | | BioAssay | Luminescence-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the lipase co-activator protein, abhydrolase domain containing 5 (ABHD5) with perilipin-5 (MLDP; PLIN5) | | AID | 602281 | | BioAssay type | screening | | Target | ABHD5 gene product [Homo sapiens] [gi:31542303] | | PubMed | | | Data Table |  |
|
| 48 | [SID56320729] | Inactive | | | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9 [AID488922, Type: screening] | KCNK9 gene product [Homo sapiens] [gi:7706135] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Inactive | | BioAssay | Primary cell-based screen for identification of compounds that inhibit the two-pore domain potassium channel KCNK9 | | AID | 488922 | | BioAssay type | screening | | Target | KCNK9 gene product [Homo sapiens] [gi:7706135] | | PubMed | | | Data Table |  |
|
| 49 | [SID56320729] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1). [AID2130, Type: screening] | protein phosphatase methylesterase 1 [Homo sapiens] [gi:7706645] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 56320729 | | CID | 54683010 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Protein Phosphatase Methylesterase 1 (PME-1). | | AID | 2130 | | BioAssay type | screening | | Target | protein phosphatase methylesterase 1 [Homo sapiens] [gi:7706645] | | PubMed | | | Data Table |  |
|
| 50 | [SID56320728] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) [AID602123, Type: screening] | DNA-binding ATP-dependent protease La [Escherichia coli str. K-12 substr. MG1655] [gi:16128424] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 56320728 | | CID | 54683010 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of Escherichia coli DNA-binding ATP-dependent protease La (eLon) | | AID | 602123 | | BioAssay type | screening | | Target | DNA-binding ATP-dependent protease La [Escherichia coli str. K-12 substr. MG1655] [gi:16128424] | | PubMed | | | Data Table |  |
|